In all cases, the BCR-ABL+ ProB-like cells displayed increased engraftment fitness, most clearly exemplified in the setting where proB cells represented only 10% of the initial inoculum and yet constituted 95% of the resultant leukaemia (Figure 4B). This evidence concerns the gene ABL1 and leukemia.